Trials / Completed
CompletedNCT01339637
Evaluation of Low Source of Signal in SCOUT DS
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 196 (actual)
- Sponsor
- VeraLight, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The overall objective of this study is to increase the number of dark skin tone individuals in the data set and evaluate if this increase in dark skin tone data has an impact on the accuracy of the SCOUT DS Diabetes Risk Score (DRS).
Conditions
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2011-09-01
- Completion
- 2011-10-01
- First posted
- 2011-04-20
- Last updated
- 2012-12-05
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01339637. Inclusion in this directory is not an endorsement.